|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/5517 | (2006.01) |
| A61K 31/573 | (2006.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61P 25/08 | (2006.01) |
| (11) | Number of the document | 3551189 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17878604.2 |
| Date of filing the European patent application | 2017-12-08 | |
| (97) | Date of publication of the European application | 2019-10-16 |
| (45) | Date of publication and mention of the grant of the patent | 2023-11-01 |
| (46) | Date of publication of the claims translation | 2024-02-12 |
| (86) | Number | PCT/US2017/065347 |
| Date | 2017-12-08 |
| (87) | Number | WO 2018/107045 |
| Date | 2018-06-14 |
| (30) | Number | Date | Country code |
| 201662432353 P | 2016-12-09 | US | |
| 201762485281 P | 2017-04-13 | US |
| (72) |
CASSELLA, James , US
GONG, Lily , US
KAMEMOTO, Edwin S. , US
|
| (73) |
Alexza Pharmaceuticals, Inc. ,
6550 Dumbarton Circle, Suite A, Fremont, CA 94555,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Alprazolamas, skirtas vartoti gydant epilepsiją |
| ALPRAZOLAM FOR USE IN TREATING EPILEPSY |
| Payment date | Validity (years) | Amount | |
| 2025-11-03 | 9 | 208.00 EUR |
| 2026-12-08 |